Label: GELUSIL- alumina, magnesia, simethicone tablet, chewable

  • NDC Code(s): 65197-300-10, 65197-300-11
  • Packager: WellSpring Pharmaceutical Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 13, 2024

If you are a consumer or patient please visit this version.

  • Active Ingredients (in each tablet)  

    Aluminum hydroxide dried gel 200 mg
    Magnesium hydroxide 200 mg
    Simethicone 25 mg

  • Purpose

    Active ingredients (in each tablet)                  Purpose
    Aluminum hydroxide dried gel 200 mg........................Antacid
    Magnesium hydroxide 200 mg....................................Antacid
    Simethicone 25 mg......................................................Antigas

  • Uses

    Relieves:

    Heartburn
    Sour stomach
    Acid indigestion
    Bloating, pressure and discomfort commonly referred to as gas
  • Warnings

    Ask a doctor before use if you have

    Kidney disease
    A magnesium restricted diet

    Ask a doctor or pharmacist before use if you are

    now taking a prescription drug.  Antacids may interact with certain prescription drugs.

    Stop use and ask a doctor if

    symptoms last more than 2 weeks

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away 1.800.222.1222

    If pregnant or breastfeeding

     ask a health professional before use.

  • Directions

    Adults and children 12 years of age and older: Chew 2 to 4 tablets.  Repeat hourly if symptoms return, or as directed by a physician
    Children under 12 of age: ask a doctor
    Do not take more than 12 tablets in a 24-hour period, or use the maximum dosage for more than 2 weeks, except under the advice and supervision of a physician
  • Other information

    Each tablet contains: magnesium 95 mg
    Store below 30°C (86°F)
    Tamper Evident. Do not use if blister or printed Gelusil foil seal is broken
    See end panel for lot number and expiration date
  • Inactive ingredients

    Dextrose, flavors, magnesium stearate, maltodextrin, microcrystalline cellulose, silica, sucralose

  • Questions?

    Call 1-844-241-5454

    © WellSpring 2018

    Sarasota, FL 34243 USA

    Made in USA

  • Principal display panel - Carton

     Gelusil Antacid Antigas 10 Blisters

    Gelusil Antacid 100 Chewable Tablets

    Gelusil Antacid Antigas Cool mint 100 Chewable Tablets
  • INGREDIENTS AND APPEARANCE
    GELUSIL 
    alumina, magnesia, simethicone tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65197-300
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) (ALUMINUM HYDROXIDE - UNII:5QB0T2IUN0) ALUMINUM HYDROXIDE200 mg
    MAGNESIUM HYDROXIDE (UNII: NBZ3QY004S) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM HYDROXIDE200 mg
    DIMETHICONE, UNSPECIFIED (UNII: 92RU3N3Y1O) (DIMETHICONE, UNSPECIFIED - UNII:92RU3N3Y1O) DIMETHICONE, UNSPECIFIED24 mg
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4) (SILICON DIOXIDE - UNII:ETJ7Z6XBU4) SILICON DIOXIDE1 mg
    Inactive Ingredients
    Ingredient NameStrength
    DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    SILICON (UNII: Z4152N8IUI)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    Product Characteristics
    ColorWHITEScoreno score
    ShapeROUNDSize16mm
    FlavorPEPPERMINTImprint Code PD;GELUSIL;034
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65197-300-1010 in 1 CARTON09/24/2008
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:65197-300-11100 in 1 BOTTLE; Type 0: Not a Combination Product12/01/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00109/24/2008
    Labeler - WellSpring Pharmaceutical Corporation (110999054)